 |
|
Noninvasive Glucose Monitoring
Comprehensive Clinical Results
Janet A. Tamada, PhD;
Satish Garg, MD;
Lois Jovanovic, MD;
Kenneth R. Pitzer, DVM, MS;
Steve Fermi, MS;
Russell O. Potts, PhD;
and the Cygnus Research Team
JAMA. 1999;282:1839-1844.
Context Intensive diabetes management using frequent blood glucose measurements to guide therapy has been shown to significantly improve short- and long-term outcomes. Development of a device that makes possible frequent, automatic, painless, and accurate measurements of glucose would facilitate intensive management.
Objective To determine the accuracy of the GlucoWatch automatic glucose biographer (Cygnus Inc) compared with that of serial blood glucose measurements.
Design Multicenter comparative study of the GlucoWatch biographer and the HemoCue blood glucose analyzer (Aktiebolaget Leo) performed between August 29 and October 17, 1998. Participants wore up to 2 biographers during the 15-hour study session and performed 2 fingersticks per hour for comparative blood glucose measurements. The biographers were calibrated with a single HemoCue measurement after a 3-hour warm-up period. Diet and insulin were manipulated to produce a broad glycemic range during the study.
Setting Controlled clinical environment at 2 diabetes centers and 3 contract research organizations in the United States.
Participants A total of 92 subjects (mean [SD] age, 42.1 [15.1] years; 59.8% women) with type 1 or 2 diabetes requiring treatment with insulin.
Main Outcome Measures Mean error, mean absolute error, correlation, slope, and intercept using Deming regression, and clinical significance of differences between biographer readings and blood glucose measurements using the Clarke error grid.
Results Results showed close tracking of blood glucose over a range of 2.2 to 22.2 mmol/L (40-400 mg/dL) for up to 12 hours using a single point calibration. The biographer readings lagged behind serial blood glucose values by a mean of 18 minutes. An analysis of 2167 data pairs shows a linear relationship (r = 0.88; slope = 1.03; intercept = -0.33 mmol/L [-6 mg/dL]) between biographer readings and serial glucose measurements. The mean absolute error between the 2 measurements was 15.6% (mean error [SD], -0.07 [1.82] mmol/L [-1 {33} mg/dL]), and 96.8% of the data fell in the therapeutically relevant regions of the error grid analysis.
Conclusion These results demonstrate close agreement between GlucoWatch biographer readings and blood glucose measurements using repeated fingerstick blood samples. The automatic, frequent, and noninvasive measurements obtained with the biographer provides more information about glucose levels than the current standard of care.
Author Affiliations: Cygnus Inc, Redwood City, Calif (Drs Tamada, Pitzer, and Potts and Mr Fermi); Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver (Dr Garg); and Sansum Medical Research Institute, Santa Barbara, Calif (Dr Jovanovic).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
November 17, 1999
JAMA. 1999;282(19):1885-1886.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Home Use of the GlucoWatch G2 Biographer in Children With Diabetes
Hathout et al.
Pediatrics 2005;115:662-666.
ABSTRACT
| FULL TEXT
Rates of Glucose Change Measured by Blood Glucose Meter and the GlucoWatch Biographer During Day, Night, and Around Mealtimes
Dunn et al.
Diabetes Care 2004;27:2161-2165.
ABSTRACT
| FULL TEXT
Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System During Hypoglycemia: Experience of the Diabetes Research in Children Network
Diabetes Care 2004;27:722-726.
ABSTRACT
| FULL TEXT
Use of the Cygnus GlucoWatch Biographer at a Diabetes Camp
Gandrud et al.
Pediatrics 2004;113:108-111.
ABSTRACT
| FULL TEXT
Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor
Boyne et al.
Diabetes 2003;52:2790-2794.
ABSTRACT
| FULL TEXT
Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects
Kulcu et al.
Diabetes Care 2003;26:2405-2409.
ABSTRACT
| FULL TEXT
Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective
Gourlay and Connolly
Perfusion 2003;18:225-231.
ABSTRACT
Use of the GlucoWatch Biographer in Children With Type 1 Diabetes
Chase et al.
Pediatrics 2003;111:790-794.
ABSTRACT
| FULL TEXT
Which Threshold to Detect Hypoglycemia?: Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity
Reach
Diabetes Care 2001;24:803-804.
FULL TEXT
Detection of Hypoglycemia With the GlucoWatch Biographer
Pitzer et al.
Diabetes Care 2001;24:881-885.
ABSTRACT
| FULL TEXT
The Role of Frequent Glucose Monitoring in Intensive Diabetes Management
The Diabetes Educator 2001;27:3-17.
Continuous Subcutaneous Glucose Monitoring in Children With Type 1 Diabetes
Chase et al.
Pediatrics 2001;107:222-226.
ABSTRACT
| FULL TEXT
Promises, Promises
Hirsch
Clin. Diabetes 2001;19:2-3.
FULL TEXT
Impact of New Technologies in Medicine: A Global Theme Issue
Mark and Glass
JAMA 1999;282:1875-1875.
FULL TEXT
|
